In 2023, the lab automation market is estimated to be worth USD 2.1 billion. With the increasing adoption of lab automation across various end-use verticals, the lab automation market is expected to grow at a CAGR of 10.1% during the forecast period, reaching USD 5.5 billion by 2033.
The major lab automation market drivers are:
| Attributes | Details |
|---|---|
| Lab Automation Market CAGR (2022 to 2032) | 10.1% |
| Lab Automation Market Size (2023) | USD 2.1 billion |
| Lab Automation Market Size (2033) | USD 5.5 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The extensive use of automated instruments is most frequently observed in academic and research institutes to boost efficiency and reduce time spent on repetitive tasks. The use of automated instruments by pharmaceutical company drug discovery units is expected to further digitalize its research phases, thrusting lab automation market growth.
One of the factors expected to accelerate lab automation market growth in the coming years is the increase in benefits offered by lab automation. Lab automation makes it easier to use laboratory equipment for repetitive tasks, as well as reduces and minimizes the physical strain caused by manual tasks, lowering costs and saving lab space. The numerous benefits provided by automated systems are expected to motivate small and large laboratories to implement these workstations.
Principal Consultant
Another factor expected to influence the lab automation market expansion soon is a rise in the demand for miniaturization. The primary reasons for implementing automated systems and workstations in clinical laboratories are to facilitate the miniaturization of research processes to devise solutions for various complex lab automation tasks in applications such as biotechnology, microbiology, and clinical chemistry, among others.
The miniaturization of these processes allows for easier cell expansion, monitoring, and cultivation, increasing turn-around times in point-of-care settings. A rise in the number of clinical applications of automated instruments for laboratories is expected to accelerate the adoption of lab automation.
Small and Medium Laboratories are Reluctant to Adopt Lab Automation Owing to High Costs
Due to financial constraints, many small and medium-sized laboratories find it difficult to invest in automation. The high maintenance and service costs associated with laboratory informatics solutions are also significant impediments
According to industry experts, the cost of maintaining IT solutions exceeds the cost of the software itself. Furthermore, low risk-taking capability and a lack of evidence on the cost-effectiveness of automation solutions for small and medium-sized laboratories are limiting the growth of the lab automation market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
During the historical reference period, the market recorded a CAGR of 9.4%. In comparison, the current forecast period is expected to register a CAGR increment to reach 10.1%.
Short-term (2023 to 2026): In the initial period, the market is secured by steady demand for pharmaceutical research. In addition, currently, there is a growing trend of automation across the pharmaceutical and healthcare sectors. Both of these are working in favor of the market even in developing nations.
Medium-term (2026 to 2029): During this phase, key players need to increasingly work on product development to sustain the fast-paced product adoption. Owing to factors such as rising diagnostic rates, globally, this period is projected to be fruitful for market growth.
Long-term (2029 to 2033): End-user demand for high-end, advanced lab automation devices is anticipated to generate lab automation market opportunities in the long run. Factors such as advancement in lab robotics technology, which is currently in its nascent stages are also expected to aid market growth.
Recently, there have been higher growth rates of molecular-based diagnostic testing, quality improvements, an increasing number of partnerships, and healthcare digitalization. The developing economies in the Asia Pacific region are now the leading lab automation markets for investment opportunities. To boost profit share, medical device manufacturing companies are concentrating on the creation of automated devices. These are used for in-vitro diagnosis and research with modern facilities. This is likely to implicitly stimulate growth in the lab automation market and strengthen software and services revenue.
The gradual expansion of the laboratory robotics market across the pioneering Asia Pacific and Middle Eastern countries could boost future sales of lab automation devices and software. The use of lab automation services has skyrocketed in the last decade. Lab automation services aid in increasing throughput at a remarkable rate, with precise motion and consistency in report generation.
With the introduction of automation techniques, the significant number of diagnosed cases has led to a threefold increase in demand for automated devices and advanced software. The aforementioned factors are expected to drive up demand for laboratory automation in large integrated healthcare systems.
According to FMI, the clinical diagnostics segment is likely to control the lab automation market, accounting for 27.1% of total revenue in 2023. This high proportion can be credited to technological progressions, an increment in automated systems presented by lab automation market players, and an increase in the prevalence of automated systems due to advantages such as the decreased risk of contamination and the reduction of human error, among others.
During the forecast period, the clinical diagnostics segment is projected to grow at a CAGR of 9.6%.
Lab automation market revenue is anticipated to be dominated by automated workstations, with integrated workflow solutions in relatively elevated demand. As clinical diagnostic studies become more sophisticated, there is a greater demand for advanced imaging, monitoring, and cell detection systems, presenting a chance for key manufacturers to launch innovative solutions.
BioMerieux is a well-known brand when it comes to automated, integrated workstations. The company markets WASPLab® integrated lab optimization and automation platforms, which offer a flexible automated specimen processing and reading solution. The PhenoMATRIXTM embedded AI and the ColibriTM colony selection module are included. These types of solutions significantly help lab technicians streamline their workflows.
The United States has the largest biopharmaceutical market, accounting for nearly one-third of the global lab automation market.
Furthermore, the Pharmaceutical Research and Manufacturers Association (PhRMA) reports that US firms conduct 50% of global research and development in pharmaceuticals, amounting to over USD 80 billion. Furthermore, with few market barriers, the United States has one of the most favorable domestic environments around the globe for pharmaceutical development and commercialization.
Among the pivotal regional markets, the North American lab automation market is expected to grow at a faster rate than the rest of the world. The USA market is projected to grow at a CAGR of 11.6% during the forecast period. The revenue from the lab automation markets in North America and Western Europe accounted for more than 60% of global lab automation market revenue.
Several of the key factors speeding the North American lab automation market are increased spending on modernizing research and drug development laboratories, a huge influx in robotics laboratory equipment sales, and the significant presence of prominent players across the United States.
By 2033, the USA market is expected to reach a valuation of USD 1.7 billion.
The Asia Pacific market is expected to grow at a 10% CAGR during the forecast period, owing to rising demand for lab automation in emerging economies like China and India.
The growing geriatric population is propelling the lab automation market forward. Due to the medical sector's attractiveness, Japan trounces the lab automation market owing to increased innovation and research in the pharmaceutical industry. Furthermore, government initiatives to mitigate healthcare spending is anticipated to catapult the lab automation market during the forecast period.
The Japanese market is anticipated to grow at a CAGR of 8.2% between 2023 to 2033.
In light of the increasing demand for multiple vaccines around the world, India's lab automation market is expected to grow significantly. The enhanced healthcare facilities and the growing number of medical centers with advanced laboratories are influencing the Indian laboratory automation market.
Rising healthcare expenditure is also spurring the lab automation market growth. The biomedical and pharmaceutical industries' technological revolution has resulted in the adoption of modular laboratories that provide a wide range of cost-effective and dependable solutions.
The Indian market is projected to grow at a CAGR of 10.9%, to reach a valuation of USD 175.4 million by 2033.
The high disease burden and increasing availability of health insurance are two factors that are predicted to significantly boost the MEA lab automation market. Furthermore, an escalation in the number of government initiatives aimed at enhancing healthcare infrastructure in Saudi Arabia and the UAE is expected to boost demand for lab automation solutions.
| Regions | North America |
|---|---|
| Countries | United States |
| CAGR | 11.6% |
| Market Value (2033) | USD 1.7 billion |
| Regions | Europe |
|---|---|
| Countries | United Kingdom |
| CAGR | 13.5% |
| Market Value (2033) | USD 156.2 Million |
| Regions | Asia Pacific |
|---|---|
| Countries | China |
| CAGR | 12.4% |
| Market Value (2033) | USD 297.4 Million |
| Regions | Asia Pacific |
|---|---|
| Countries | India |
| CAGR | 9.7% |
| Market Value (2033) | USD 175.4 Million |
| Regions | Asia Pacific |
|---|---|
| Countries | Japan |
| CAGR | 8.2% |
| Market Value (2033) | USD 447.8 Million |
Abbott Laboratories, Agilent Technologies, Perkin Elmer, Inc, Thermo Fisher Scientific, Inc, Siemens Healthcare, Danaher Corporation, Becton, Dickinson and Company, and Transcriptic, Inc. are key competitors in the lab automation market. These players are constantly focusing on integrating innovative laboratory automation solutions to enter lucrative markets.
Furthermore, many companies are forming strategic and collaborative approaches with numerous companies to boost their lab automation market share and profitability.
Key Market Developments:
| Company | Beckman Coulter Life Sciences |
|---|---|
| Details | Beckman Coulter Life Sciences is a Danaher Corporation company that provides life sciences lab automation and innovation |
| Recent Developments | In March 2022, the company introduced the CellMek SPS, a powerful solution to manual sample preparation and data management bottlenecks in clinical flow cytometry. This fully automated sample preparation system (SPS) provides on-demand processing for a variety of sample types, allowing laboratories to expand their capabilities |
| Company | Strateos Inc. |
|---|---|
| Details | Strateos, Inc., is a pioneer in the creation of remote access laboratories and lab automation software for life science research, |
| Recent Developments | In April 2022, the company announced the unveiling of an integrated solution for small molecule discovery programs looking for a faster, automated way to complete Design, Make, Test, and Analyze (DMTA) cycles. |
| Company | Biosero |
|---|---|
| Details | Biosero is a BICO company that develops laboratory automation solutions to orchestrate scientific discoveries. |
| Recent Developments |
In March 2022, the company announced the release of several new products and features in the company's Green Button Go software suite. These products provide advanced capabilities to assist customers in streamlining, controlling, and producing better results from their automated laboratory systems. Green Button Go software from Biosero enables scientists to automate workflows ranging from a single workstation to operations that span multiple labs |
| Company | Tecan Group LTD |
|---|---|
| Details | Tecan Group Ltd. Is a Swiss company providing best-in-class laboratory solutions primarily for pharmaceuticals, diagnostics, and research. |
| Recent Developments | In February 2020, the company introduced the Rapid EZ DNA sequence portfolio by evolving the DreamPrep NGS flexible workflow automated liquid handling platform. |
| Company | Thermo Fisher Scientific Inc |
|---|---|
| Details | Thermo Fisher Scientific Inc. is a well-known American, supplier of instrumentation, software as well as consumables. |
| Recent Developments |
In March 2022, Thermo Fisher Scientific and Hamilton Company launched a forensic laboratory-qualified automated nucleic acid extraction platform. Thermo Fisher has combined its expertise in magnetic particle technology and PrepFiler extraction chemistry with Hamilton's liquid handling capabilities. This has reduced sample preparation time; now, up to 96 samples can be processed simultaneously in deep-well plate format for DNA quantification and STR analyses. |
| Company | Hamilton |
|---|---|
| Details | Hamilton predominantly focuses on the manufacturing and customization of instruments and devices, catering to diverse industries |
| Recent Developments | In January 2020, the Hamilton Group worked with Enable Biosciences to develop the automated ultra-sensitive antibody detection assay platform. |
The global lab automation market is estimated to generate a revenue of around USD 2.1 billion in 2023.
Abbott, Agilent, and Perkin Elmer are the top performing market players.
The regional market value in North America is expected to become USD 1.7 billion by 2033.
China Lab automation market is projected to follow an astounding 12.4% CAGR until 2033.
The demand for lab automation services in the United Kingdom could witness 13.5% CAGR through 2033.
1. Executive Summary | Lab Automation Market 2. Market Overview 3. Market Background 4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Component Type 5.1. Biochemistry Devices 5.2. Molecular Devices 5.3. Hematology Devices 5.4. Immunology Devices 5.5. Microbiology Devices 5.6. Others 6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 6.1. Life Science R&D 6.2. Drug Discovery 6.3. Diagnostics 6.4. Pharmaceutical Companies 6.5. Hospitals & Diagnostics Centers 6.6. Educational Institutes 6.7. Contract Research Organizations 6.8. Research Institutes 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 7.1. North America 7.2. Latin America 7.3. Western Europe 7.4. Eastern Europe 7.5. Asia Pacific Excluding Japan 7.6. Japan 7.7. Middle East & Africa (MEA) 8. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 9. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 10. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 11. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12. Asia Pacific Excluding Japan Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13. Japan Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 14. Middle East & Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 15. Key Countries Market Analysis 16. Market Structure Analysis 17. Competition Analysis 17.1. Abbott Laboratories 17.2. Agilent Technologies 17.3. Perkin Elmer, Inc 17.4. Thermo Fisher Scientific, Inc 17.5. Siemens Healthcare 17.6. Danaher Corporation 17.7. Becton 17.8. Dickinson and Company 17.9. Transcriptic, Inc. 17.10. Tecan Group 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Lab Automation Market
